City

Besancon (1)

Chorzow (1)

Krakow (1)

Lodz (1)

Mexico (1)

Warsaw (1)

Wroclaw (1)

Condition

Multiple Indications Cancer (2)

Overall Status

Active, not recruiting (1)

Withdrawn (1)

Phase

phase 2 (1)

Sponsor

Bristol-Myers Squibb (2)

Collaborator

Intervention

dasatinib (1)

non-interventional (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

multiple indications cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

Withdrawn

Multiple Indications Cancer

Non-Interventional

Mexico, Distrito Federal, Mexico

Local Institution

May 25, 2022

Multiple Indications Cancer Trial in France, Poland (Dasatinib)

Active, not recruiting

Multiple Indications Cancer

Dasatinib

Besancon, France
+5 more

Dec 2, 2021